Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Published Online: 2021-04-22
Journal: Nature MedicineLoading...
Authors: David F. McDermott•Elizabeth R. Plimack•Eric Jonasch•Jaime R. Merchan•Kyriakos P. Papadopoulos•Leonard J. Appleman•M. Dror Michaelson•Naseem J. Zojwalla•Rodolfo F. Perini•Sanjay Thamake•Todd M. Bauer•Toni K. Choueiri
